[1] 李琳霈, 潘博.潘敏求主任医师治疗肝癌经验[J].湖南中医杂志, 2011, 27(3): 46
LI LP, PAN B.Chief physician Pan Minqiu's experience in treating liver cancer[J].Hunan J Tradit Chin Med, 2011, 27(3):46
[2] 潘敏求, 潘博.健脾理气、化瘀软坚、清热解毒法治疗原发性肝癌的体会[J].湖南中医杂志, 2009, 25(6):21
PAN MQ, PAN B.Experience in treating primary liver cancer with the methods of strengthening the spleen and regulating qi, removing blood stasis and softening firmness, clearing away heat and detoxification[J].Hunan J Tradit Chin Med, 2009, 25(6):21
[3] 潘敏求, 潘博.原发性肝癌中医临床和实验研究的回顾与展望[J].湖南中医杂志, 2002, 18(4): 1
PAN MQ, PAN B.Retrospect and prospect of TCM clinical and experimental research on primary liver cancer[J].Hunan J Tradit Chin Med, 2002, 18(4): 1
[4] 杨俊, 古陟欣, 贺莲, 等. 一种治疗脂肪肝、酒精性肝炎及并发症的中药复方制剂:中国, CN101745077A[P].2010-06-23
YANG J, GU DX, HE L, et al. A Chinese medicine compound preparation for the treatment of fatty liver. A Chinese medicine compound preparation for the treatment of fatty liver, alcoholic hepatitis and complications: China, CN101745077A[P].2010-06-23
[5] 贺珊, 廖长秀.中药治疗肝癌机制的研究进展[J].中成药, 2017, 39(1): 155
HE S, LIAO CX.Research progress on mechanism of traditional Chinese medieine in treating liver cancer[J].Chin Tradit Pat Med, 2017, 39(1): 155
[6] 樊素梅. 肝复乐胶囊联合肝动脉栓塞化疗治疗晚期肝癌的临床研究[J].临床医药文献电子杂志, 2014, 1(1):53
FAN SM.Clinical study of Ganfule capsule combined with hepatic artery embolization chemotherapy in the treatment of advanced liver cancer[J].J Clin Med Liter, 2014, 1(1):53
[7] 刘冬梅. 肝复乐胶囊联合肝动脉栓塞化疗治疗晚期肝癌的疗效观察[J].临床医药文献电子杂志, 2016, 3(2): 235
LIU DM.Observation on the effect of Ganfule capsule combined with hepatic artery embolization chemotherapy in the treatment of advanced liver cancer[J].J Clin Med Liter, 2016, 3(2): 235
[8] 潘博. 潘敏求主任医师治疗肝癌经验[J].湖南中医杂志, 2011, 27(3): 46
PAN B, Chief physician Pan Minqiu's experience in treating liver cancer[J].Hunan J Tradit Chin Med, 2011, 27(3):46
[9] 刘艳. 高效液相色谱法测定肝复乐胶囊中橙皮苷的含量[J].国际医药卫生导报, 2008, 14(12): 96
LIU Y.Determination of Hesperidin in Ganfule capsules by HPLC[J].Inter Med Health Guid News, 2008, 14(12): 96
[10] 张铁军, 许浚, 韩彦琪, 等. 中药大品种质量标准提升研究的思路与实践[J].天津中医药, 2017, 34(1):4
ZHANG TJ, XU J, HAN YQ, et al. Thoughts and practice of research on improving quality standards of large varieties of traditional Chinese medicine[J].Tianjin J Tradit Chin Med, 2017, 34(1):4
[11] 杨洁. 陈皮化学成分的研究[D].长春:吉林大学, 2013
YANG J.Study on The Chemical Composition of Tangerine Peel[D]. Changchun: Jilin University, 2013
[12] 罗舟. 蒙古黄芪的化学成分研究[D].沈阳:沈阳药科大学, 2012
LUO Z.Study on The Chemical Constituents of Mongolian Astragalus[D]. Shenyang: Shenyang Pharmaceutical University, 2012
[13] 毕志明, 余庆涛, 李萍, 等. 蒙古黄芪地上部分的黄酮类成分[J].中国天然药物, 2007, 5(4): 263
BI ZM, YU QT, LI P, et al. Flavonoids in the aerial parts of Astragalus mongolica[J].Chin J Nat Med, 2007, 5(4): 263
[14] 王鑫, 赵焕新, 牟艳玲, 等. 苏木的化学成分[J].食品与药品, 2013(2): 14
WANG X, ZHAO HX, MOU YL, et al. Chemical composition of hematoxylin[J].Food Drug, 2013(2): 14 .
[15] 马莹, 郑伟然, 王振中, 等. 桂枝茯苓胶囊中三站酸类成分的UPLC/Q-T0F-MS指纹图谱研究[J].中草药, 2019, 50(3): 89
MA Y, ZHENG WR, WANG ZZ, et al. Study on UPLC/Q-T0F-MS fingerprint of triterpene acids in Guizhi Fuling capsules[J].Chin Tradit Herb Drugs, 2019, 50(3): 89
[16] 高慧敏, 王智民.白木通中一个新的三萜皂昔类化合物[J].药学学报, 2006, 41(9):36
GAO HM, WANG ZM.A new triterpene saponin compound from Baimutong[J].Acta Pharm Sin, 2006, 41(9): 36
[17] 孙云超, 白珺, 胡佳丽, 等. 云南产茯苓的化学成分研究[J].广州化工, 2015, 43(6):57
SHUN YC, BAI J, HU JL, et al. Study on the chemical constituents of Poria produced in Yunnan[J].Guangzhou Chem Ind, 2015, 43(6):57
[18] 马晓丰. 蒙古黄芪的化学成分研究[D].沈阳:沈阳药科大学, 2003
MA XF.Study on the Chemical Constituents of Mongolian astragalus[D]. Shenyang: Shenyang Pharmaceutical University, 2003
[19] WANG ZQ, XU FM.Studies on the constituents of Scutellariabarbata[J].Chin Chem Lett, 1996, 7(4):333
[20] 聂小安, 马自超, 吴伟志, 等. 姜黄色素的分离及其结构鉴定[J].中国野生植物资源, 1993, 1(3):4
NIE XA, MA ZC, WU WZ, et al. Isolation and structure identification of curcumin[J].Chin Wild Plant Res, 1993, 1(3):4
[21] 黄周锋, 胡筱希, 陆国寿, 等. 基于HPLC-LTQ/0rbitrap MS法的四味脾胃舒颗粒化学成分研究[J].天津中医药, 2019, 36(3): 304
HUANG ZF, HU XX, LU GS, et al. Study on the chemical constituents of Siwei Piweishu granules based on HPLC-LTQ/Orbitrap MS[J].Tianjin J Tradit Chin Med, 2019, 36(3): 304
[22] 窦春青, 金鑫, 李涛.肝复乐胶囊联合索拉非尼治疗晚期肝癌的临床研究[J].现代药物与临床, 2017, 32(4): 644
DOU CQ, JIN X, LI T.Clinical study of Ganfule capsule combined with sorafenib in the treatment of advanced liver cancer[J].Drugs Clin, 2017, 32(4): 644
[23] 高家荣, 朱梦情, 汪小莉, 等. UPLC-Q-T0F-MS~E技术结合UNIFI软件分析黄地安消胶囊化学成分[J].中国中药杂志, 2020, 45(10): 2395
GAO JR, ZHU MQ, WANG XL, et al. UPLC-Q-T0F-MS~E technology combined with UNIFI software to analyze the chemical composition of Huangdi Anxiao capsules[J].Chin J Chin Mat Med, 2020, 45(10): 2395
[24] 张蕻, 田峰, 任连生, 等. 苏木精对移植性小鼠肝癌H22的抑制作用[J].中国药物与临床, 2006, 6(4): 294
ZHANGS, TIAN F, REN LS, et al. Inhibitory effect of hematoxylin on transplanted mouse liver cancer H22[J].Chin Remed Clin, 2006, 6(4): 294
[25] 李争春. 苏木有效成分筛选及其化学组成分析[D].太原:山西大学, 2014
LI ZC.Screening of the Effective Components of Sappan and Its Chemical Composition Analysis[D]. Taiyuan: Shanxi University, 2014
[26] RADHA K, MAHESHW ARI, AN0OP K, et al. Multiple biological activities of curcumin: a short review.[J].Life Sci, 2006, 78(18): 2081
[27] AGGRWAL BB, HARIKUMAR KB.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases[J].Int J Biochem Cell B, 2009, 41(1):1
[28] 李露, 戴婷, 李小龙, 等. 苦杏仁苷药理作用的研究进展[J].吉林医药学院学报, 2016, 37(1): 63
LI L, DAIT, LI XL, et al. Research progress on the pharmacological effects of amygdalin[J].J Jilin Med Univ, 2016, 37(1):63
[29] 王玉, 杨雪, 夏鹏飞, 等. 大黄化学成分、药理作用研究进展及质量标志物的预测分析[J].中草药, 2019, 50(19): 4821
WANG Y, YANG X, XIA PF, et al. Research progress on chemical constituents and pharmacological effects of rhubarb and predictive analysis of quality markers[J].Chin Tradit Herb Drugs, 2019, 50(19): 4821
[30] SHIU LY, HUANG HH, CHEN CY, et al. Reparative and toxicity-reducing effects of liposome-encapsulated saikosaponin in mice with liver fibrosis[J].Bioence Reports, 2020, 40(8): 1
[31] 刘静, 李晓宇, 吴恺怿, 等. 小柴胡汤治疗肝炎时出现肝损伤的“效-毒”作用网络分析与机制预测[J].中草药, 2019, 50(21):5135
LIU J, LI XY, WU KY, et al. “Efficacy-toxicity" network analysis and mechanism prediction of liver injury in Xiaochaihu decoction in the treatment of hepatitis[J].Chin Tradit Herb Drugs, 2019, 50(21):5135
[32] 黄斯, 潘雨薇, 蓝海, 等. 茯苓酸药理学研究进展[J].中成药, 2015, 37(12): 2719
HUANG s, PAN YW, LAN H, et al. Progress in the pharmacology of poriaic acid[J].Chin Tradit Pat Med, 2015, 37(12): 2719
[33] 李月菲, 田从魁, 孟嘉星, 等. 沉香的化学成分及药理作用研究进展[J].国际药学研究杂志, 2019, 46(7): 498
LI YF, TIAN CK, MENG JX, et al. Research progress on chemical constituents and pharmacological efects of agarwood[J].J Inter Pharm Res, 2019, 46(7): 498
[34] 张晓娟, 左冬冬. 白术化学成分及药理作用研究新进展[J].中医药信息, 2018, 35(6): 101
ZHANG XJ, ZUO DD.New progress in research on chemical constituents and pharmacological effects of Atractylodes macrocephala[J].Inf Tradit Chin Med, 2018, 35(6): 101
[35] WU X, XIA HL, HUANG LH, et al. Study on the chemical constituents of Rhizoma Cyperi[J].J Chin Mate Med, 2008, 31(7): 990
[36] 李柯柯, 任顺成. 陈皮中黄酮类化合物的研究进展[J].食品研究与开发, 2017, 38(17):221
LI KK, REN SC.Research progress of flavonoids in orange pee[J].Food Res Develop, 2017, 38(17): 221
[37] 叶潇, 朱萱萱, 刘婷, 等. 川木通对大鼠利尿作用及其物质基础研究[J].中国中药杂志, 2019, 44(9): 1889
YE X, ZHU XX, LIU T, et al. Study on diuretic effect of Chuanmutong on rats and its material basis[J].Chin J Chin Mater Med, 2019, 44(9): 1889
[38] 龙宇, 向燕, 谭裕君, 等. 黄芩苷药理作用及新剂型的研究进展[J].中草药, 2019, 50(24): 6142
LONG Y, XIANG Y, TAN YJ, et al.Research progress on pharmacological efctse and new dosage forms of baicalin[J].Chin Tradit Herb Drugs, 2019, 50(24): 6142
[39] 王庆华, 杜婷婷, 张智慧, 等. 绿原酸的药理作用及机制研究进展[J].药学学报, 2020, 55(10): 2273
WANG QH, DU TT, ZHANG ZH, et al. Research progress on pharmacological effects and mechanism of chlorogenic acid[J].Acta Pharm Sin, 2020, 55(10): 2273
[40] 卢伟, 牟雄军, 杨光义, 等. 中药重楼药理活性研究进展[J].中国药师, 2017, 20(5): 896
LU W, MOU XJ, YANG GY, et al. Research progress on the pharmacological activity of Chinese medicine Zhonglou[J].Chin Pharm, 2017, 20(5): 896
